Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) for its Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial, the generic equivalent of Lupron Injection (1 mg/0.2 mL)
Merck is reportedly nearing an agreement to acquire Cidara Therapeutics, in a deal that would value the biotechnology firm above its current $3.3 billion market capitalization
CN Tech Engineers (CN Water), a major Indian provider of high-purity water solutions for pharmaceutical and industrial use, has entered into a strategic alliance with Taiwan Pure Water Technology Co., Ltd. (Taipure), a leader in ultrapure water (UPW)
The US Food and Drug Administration (USFDA) has finally approved Alembic Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Dexlansoprazole Delayed-Release Capsules
The highly anticipated 3rd Edition of PACK.Nxt returns to The Lalit in Mumbai on 16th December 2025, the only dedicated event on Smart & Sustainable Packaging in India.
.png)
Lupin Manufacturing Solutions (LMS), a fully owned subsidiary of a multinational pharmaceutical company Lupin, has also established a separate Oncology Block in its Vizag plant in India. This high-capacity unit will increase the end-to-end CDMO...
The Pan American Health Organization (PAHO) has placed a $4.75 million (Rs 41 crore) order with Panacea Biotec to supply the Easyfive TT vaccine under a long-term contract
BASF and Beyond Suncare express their approval of the World Health Organization's (WHO) decision to incorporate broad-spectrum sunscreen with a high SPF into the 24th edition of the Model List of Essential Medicines (EML) and the 10th edition of the
Indian pharma companies Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have achieved a breakthrough in China after securing key bids to supply generic drugs under the country’s latest volume-based procurement (VBP) program...
Ascelia Pharma AB (publ), a biotech focused on improving the life of people living with rare cancer conditions, announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance
, CDSCO.jpg)